title: Umeclidinium bromide/vilanterol trifenatate, perampanel, and eslicarbazepine acetate.
authors: Daniel A
authors: DA
authors: Hussar
authors: Nabil
authors: N
authors: Dharsi
mesh_terms: D001592:Benzyl Alcohols / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D006801:Humans; D009570:Nitriles; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D011728:Pyridones / Q000627:therapeutic use*; D011812:Quinuclidines / Q000627:therapeutic use*; D061567:Voltage-Gated Sodium Channel Blockers / Q000627:therapeutic use*
chemical_list: D001592:Benzyl Alcohols; D002722:Chlorobenzenes; D003984:Dibenzazepines; C573971:GSK573719; D009570:Nitriles; D011728:Pyridones; D011812:Quinuclidines; D061567:Voltage-Gated Sodium Channel Blockers; C550468:vilanterol; C416835:eslicarbazepine acetate; C551441:perampanel